Rezolve AI PLC (RZLV)
NASDAQ: RZLV · Real-Time Price · USD
3.000
+0.050 (1.69%)
Aug 8, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $5.75, which forecasts a 91.67% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $8.50.
Price Target: $5.75 (+91.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +183.33% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +33.33% | Jun 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +33.33% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +33.33% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +33.33% | Apr 1, 2025 |
Financial Forecast
Revenue This Year
37.55M
from 187.79K
Increased by 19,894.36%
Revenue Next Year
101.93M
from 37.55M
Increased by 171.47%
EPS This Year
-0.30
from -1.06
EPS Next Year
-0.21
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 63.0M | 189.0M |
| Avg | 37.5M | 101.9M |
| Low | 19.6M | 73.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 33,448.5% | 403.4% |
| Avg | 19,894.4% | 171.5% |
| Low | 10,337.3% | 95.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.12 | - |
| Avg | -0.30 | -0.21 |
| Low | -0.70 | -0.69 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.